Rating History for Lineage Cell Therapeutics Inc. (LCTX) by Canaccord

More Stocks Rated by Canaccord | Latest Ratings for LCTX
Date Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
4/28/2026 John Newman New Coverage Buy
(N/A)		 9.00
(N/A)		 1.55
(0.98)		 -36.77% Details